Uptake and Acceptability of Information and Communication Technology in a Community-Based Cohort of People Who Inject Drugs: Implications for Mobile Health Interventions

Background Mobile phone and Internet-based technologies are increasingly used to disseminate health information and facilitate delivery of medical care. While these strategies hold promise for reducing barriers to care for medically-underserved populations, their acceptability among marginalized populations such as people who inject drugs is not well-understood. Objective To understand patterns of mobile phone ownership, Internet use and willingness to receive health information via mobile devices among people who inject drugs. Methods We surveyed current and former drug injectors participating in a longitudinal cohort study in Baltimore, Maryland, USA. Respondents completed a 12-item, interviewer-administered questionnaire during a regular semi-annual study visit that assessed their use of mobile technology and preferred modalities of receiving health information. Using data from the parent study, we used logistic regression to evaluate associations among participants’ demographic and clinical characteristics and their mobile phone and Internet use. Results The survey was completed by 845 individuals, who had a median age of 51 years. The sample was 89% African-American, 65% male, and 33% HIV-positive. Participants were generally of low education and income levels. Fewer than half of respondents (40%) indicated they had ever used the Internet. Mobile phones were used by 86% of respondents. Among mobile phone owners, 46% had used their phone for text messaging and 25% had accessed the Internet on their phone. A minority of respondents (42%) indicated they would be interested in receiving health information via phone or Internet. Of those receptive to receiving health information, a mobile phone call was the most favored modality (66%) followed by text messaging (58%) and Internet (51%). Conclusions Utilization of information and communication technology among this cohort of people who inject drugs was reported at a lower level than what has been estimated for the general U.S. population. Our findings identify a potential barrier to successful implementation of mobile health and Internet-based interventions for people who inject drugs, particularly those who are older and have lower levels of income and educational attainment. As mobile communication technology continues to expand, future studies should re-examine whether mHealth applications become more accessible and accepted by socioeconomically disadvantaged groups.

[1]  Stephanie J Mitchell,et al.  Internet and Mobile Technology Use Among Urban African American Parents: Survey Study of a Clinical Population , 2012, Journal of medical Internet research.

[2]  R. Bollinger,et al.  The Exposure Assessment in Current Time Study: Implementation, Feasibility, and Acceptability of Real-Time Data Collection in a Community Cohort of Illicit Drug Users , 2013, AIDS research and treatment.

[3]  R. Westergaard,et al.  Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users , 2013, AIDS.

[4]  S. Himelhoch,et al.  Acceptability of Mobile Phone Technology for Medication Adherence Interventions among HIV-Positive Patients at an Urban Clinic , 2013, AIDS research and treatment.

[5]  K. Patel,et al.  Frailty, HIV Infection, and Mortality in an Aging Cohort of Injection Drug Users , 2013, PloS one.

[6]  Richard D Moore,et al.  Sustained viral suppression in HIV-infected patients receiving antiretroviral therapy. , 2012, JAMA.

[7]  G. Donenberg,et al.  Prevalence of psychiatric disorders among young injection drug users. , 2012, Drug and alcohol dependence.

[8]  Francis Collins,et al.  How to fulfill the true promise of "mHealth": Mobile devices have the potential to become powerful medical tools. , 2012, Scientific American.

[9]  B. Lau,et al.  HIV infection, immune suppression, and uncontrolled viremia are associated with increased multimorbidity among aging injection drug users. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  S. Springer High rates of depressive symptomatology among injecting drug users in Saskatoon, Canada , 2011, Evidence Based Mental Health.

[11]  D. Blazer,et al.  Depressive Symptoms, Substance Use, and HIV-Related High-Risk Behaviors Among Opioid-Dependent Individuals: Results From the Clinical Trials Network , 2011, Substance use & misuse.

[12]  D. Epstein,et al.  Stress in the daily lives of cocaine and heroin users: relationship to mood, craving, relapse triggers, and cocaine use , 2011, Psychopharmacology.

[13]  T. Sterling,et al.  Latent TB infection treatment acceptance and completion in the United States and Canada. , 2010, Chest.

[14]  M. Casals,et al.  Tuberculosis treatment adherence and fatality in Spain , 2009, Respiratory research.

[15]  D. Celentano,et al.  Nonstructured Treatment Interruptions Among Injection Drug Users in Baltimore, MD , 2009, Journal of acquired immune deficiency syndromes.

[16]  S. Cole,et al.  Racial Disparities in HIV Virologic Failure: Do Missed Visits Matter? , 2009, Journal of Acquired Immune Deficiency Syndromes.

[17]  Joseph Finkelstein,et al.  Digital Divide: Variation in Internet and Cellular Phone Use among Women Attending an Urban Sexually Transmitted Infections Clinic , 2009, Journal of Urban Health.

[18]  Mustapha Mezghanni,et al.  Real-time electronic diary reports of cue exposure and mood in the hours before cocaine and heroin craving and use. , 2009, Archives of general psychiatry.

[19]  D. Vlahov,et al.  Limited Uptake of Hepatitis C Treatment Among Injection Drug Users , 2008, Journal of Community Health.

[20]  Richard D Moore,et al.  Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic , 2006, AIDS.

[21]  R. Brooner,et al.  Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. , 2004, Drug and alcohol dependence.

[22]  A Munoz,et al.  The Alive Study: A Longitudinal Study of HIV-1 Infection in Intravenous Drug Users: Description of Methods , 1991, NIDA research monograph.